Financials
- Market Capitalization 5.57 B
- Employee 103
- Founded 2018
- CEO N/A
- Website www.erasca.com
- Headquarter Delaware, United States
- FIGI BBG00MTSR883
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1198 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 309.25 USD | -2.21% | -2.80% | +21.27% | +65.27% | 6.20 B USD | ||
| 1246 | BLTE Belite Bio Inc - American Depositary Shares | 147.03 USD | -1.54% | -5.14% | +4.41% | +128.59% | 5.78 B USD | ||
| 1282 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 98.64 USD | +1.07% | +5.68% | +18.29% | +388.56% | 5.39 B USD | ||
| 1301 | TVTX Travere Therapeutics, Inc. - Common Stock | 56.29 USD | -0.53% | -2.58% | +6.63% | +95.66% | 5.23 B USD |
Frequently asked questions about Erasca, Inc. - Common Stock
What is the Erasca, Inc. - Common Stock stock price today?
The current price of Erasca, Inc. - Common Stock (ERAS) is 17.9. Over the past 24 hours, the stock has changed by -3.40%. Follow the ERAS chart for real-time price dynamics.
What is the stock ticker of Erasca, Inc. - Common Stock?
Erasca, Inc. - Common Stock trades under the ticker ERAS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Erasca, Inc. - Common Stock stock going up?
ERAS has changed by -5.14% over the last week, +27.22% over the last month, and +1126.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Erasca, Inc. - Common Stock net income for the last quarter?
Erasca, Inc. - Common Stock reported net income of -183.44 M for the last quarter. The previous quarter showed -29.09 M, which means net income changed by -530.55%.
How many employees does Erasca, Inc. - Common Stock have?
As of the latest available data, Erasca, Inc. - Common Stock has 103 employees. Workforce size can provide additional context about the company's scale and operations.
What is Erasca, Inc. - Common Stock EBITDA?
Erasca, Inc. - Common Stock EBITDA is -186.48 M, and its EBITDA margin is -26.26 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Erasca, Inc. - Common Stock stock?
You can buy Erasca, Inc. - Common Stock (ERAS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Erasca, Inc. - Common Stock stock?
Investing in Erasca, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ERAS chart and related analysis on metatrader.com as part of your research.